Despite issuing the warning, the WHO has already started negotiations with China over the distribution of Beijing’s own vaccine. Although clinical trials have not been fully completed in China, the vaccine has been handed to essential workers and other groups at high risk. Speaking on Monday, the WHO’s director-general, Tedros Adhanom Ghebreyesus, stated distributing the coronavirus vaccine will be difficult without appropriate buy-ins from other countries.
He added: “What we’re proposing is: We have to vaccinate some people in all countries rather than all people in some countries.
“And for this I know political leaders will have difficulty, especially considering their own respective constituencies.”
Negotiations between the WHO and China, concern using the country’s vaccines on a list for emergency use.
Socorro Escalate, the coordinator for essential medicines and health technologies in the Western Pacific region, made the statement during an online press conference.
WHO: Organization delivers vaccine warning
Coronavirus: China is developing several vaccines
This emergency list allows unlicensed vaccines and treatments, to be assessed in order to expedite their availability.
He added: “Potentially through this emergency use listing the quality and safety of these vaccines and efficacy could be assessed and then this could be made available for our licensees.”
There are currently five vaccines being developed in China.
Shenzhen Kangtai Biological Products were the latest to announce the clinical trial for their drug last week.
China: The drugs have not completed trials yet
There are two further vaccines being developed by state-backed, National Biotec Group, which are in the final stage of trials.
Another is being developed by Sinovac Biotech, while the Chinese Academy Medical Sciences’ vaccine, is currently in mid-stage trials.
The WHO also helped launch COVAX, which brings together government and countries across the world to develop vaccines.
This initiative will help low-income countries to receive a vaccine and has 156 countries involved in drug development.
Farage unveils Trump’s strategic move in last bid to win US election [Update]
Boris Johnson vows to reduce mortgage deposits [Latest]
Scotland’s travel quarantine system exposed as just ONE fine issued [Insight]
Coronavirus: WHO chief Tedros Adhanom Ghebreyesus
Coronavirus: The vaccines are on the emergency list
The US has criticsed alleged links between China and the WHO.
Following allegations of collusion over the information regarding the coronavirus pandemic, Donald Trump pulled £47million $62 million worth of funding from the WHO.
The US has called on the organisation to reform before any potential funding is restored.
Mr Trump has also insisted China must answer questions of how the outbreak started.
Countries with exemptions
Announcing the withdrawal of funding for the WHO, he said: “The world needs answers from China.
“Chinese officials ignored their reporting obligations to the World Health Organization and pressured the World Health Organization to mislead the world when the virus was first discovered by Chinese authorities.
“Countless lives have been taken, and profound economic hardship has been inflicted all around the globe.
“We have detailed the reforms that it must make and engage with them directly, but they have refused to act.
The WHO claimed there must be complete buy-in
“Because they have failed to make the requested and greatly needed reforms, we will be today terminating our relationship with the World Health Organization and redirecting those funds to other worldwide and deserving urgent global public health needs.”
China criticised the move from Donald Trump.
WHO has denied any claims that it colluded with China over the coronavirus outbreak, while also agreeing to a review into the agency’s handling of the pandemic.